Our mission is advancing minimally invasive treatment strategies for pressing age-related chronic diseases, such as bone loss and disc degeneration. Navigating the interdisciplinary landscape, we blend expertise in biomaterials, 3D (bio)printing, and biomolecular engineering. Recognizing the crucial role of mechanical signals from the extracellular matrix (ECM) in cellular behavior, our approach integrates mechanobiological studies. By fusing material science, advanced 3D biomanufacturing, and comprehension of mechanobiology, we aim to craft precise and effective injectable functionalized scaffolds for minimally invasive tissue regeneration.